




Searching News Database: cytomegalovirus
HSMN NewsFeed - 20 Apr 2021
Lilly and Incyte's Baricitinib Improved Hair Regrowth for Alopecia Areata Patients in Second Phase 3 Study
Lilly and Incyte's Baricitinib Improved Hair Regrowth for Alopecia Areata Patients in Second Phase 3 Study
HSMN NewsFeed - 16 Mar 2020
Lilly Receives FDA Breakthrough Therapy Designation for Baricitinib for the Treatment of Alopecia Areata
Lilly Receives FDA Breakthrough Therapy Designation for Baricitinib for the Treatment of Alopecia Areata
HSMN NewsFeed - 26 Apr 2017
FDA Approves XATMEP(TM), the First and Only Ready-To-Use Methotrexate Oral Solution
FDA Approves XATMEP(TM), the First and Only Ready-To-Use Methotrexate Oral Solution
HSMN NewsFeed - 25 May 2016
Roche announces the first FDA-approved CMV test for use in hematopoietic stem cell transplant recipients
Roche announces the first FDA-approved CMV test for use in hematopoietic stem cell transplant recipients
HSMN NewsFeed - 28 Dec 2015
Chimerix Announces Top-Line Results From Phase 3 SUPPRESS Trial of Brincidofovir
Chimerix Announces Top-Line Results From Phase 3 SUPPRESS Trial of Brincidofovir
HSMN NewsFeed - 21 Dec 2015
Roche receives FDA approval for HIV-1 viral load test on the cobas(R) 6800/8800 Systems
Roche receives FDA approval for HIV-1 viral load test on the cobas(R) 6800/8800 Systems
HSMN NewsFeed - 15 Jan 2015
Seres Health Appoints Shelley Trucksis, Ph.D., M.D. as Executive Vice President and Chief Medical Officer
Seres Health Appoints Shelley Trucksis, Ph.D., M.D. as Executive Vice President and Chief Medical Officer
HSMN NewsFeed - 9 Apr 2014
Chimerix Announces Appointment of M. Michelle Berrey, M.D., M.P.H. as Chief Executive Officer
Chimerix Announces Appointment of M. Michelle Berrey, M.D., M.P.H. as Chief Executive Officer
HSMN NewsFeed - 29 Jan 2013
Bionor Pharma Appoints Anker Lundemose as President and Chief Executive Officer
Bionor Pharma Appoints Anker Lundemose as President and Chief Executive Officer
HSMN NewsFeed - 17 Apr 2012
QIAGEN Receives FDA Clearances for Rotor-Gene Q MDx Instrument and Compatible Influenza A/B Assay
QIAGEN Receives FDA Clearances for Rotor-Gene Q MDx Instrument and Compatible Influenza A/B Assay
HSMN NewsFeed - 6 Sep 2011
Inovio Pharmaceuticals Adds Two Medical Innovators to Its Scientific Advisory Board
Inovio Pharmaceuticals Adds Two Medical Innovators to Its Scientific Advisory Board
HSMN NewsFeed - 6 May 2010
Chimerix Appoints Thomas Pitler, Ph.D., Vice President, Business Development
Chimerix Appoints Thomas Pitler, Ph.D., Vice President, Business Development
HSMN NewsFeed - 8 Jun 2009
ViroPharma Announces Appointment of Frank Baldino, Jr., Ph.D. to Board of Directors
ViroPharma Announces Appointment of Frank Baldino, Jr., Ph.D. to Board of Directors
HSMN NewsFeed - 16 Feb 2009
AlphaVax Announces New Vice President of Regulatory, Quality and Clinical Operations
AlphaVax Announces New Vice President of Regulatory, Quality and Clinical Operations
HSMN NewsFeed - 13 Feb 2009
ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
HSMN NewsFeed - 9 Feb 2009
ViroPharma Reports Results of Phase 3 Clinical Trial for Maribavir in Bone Marrow Transplant Patients
ViroPharma Reports Results of Phase 3 Clinical Trial for Maribavir in Bone Marrow Transplant Patients
HSMN NewsFeed - 2 Feb 2009
pSivida Corp. Names Paul Ashton, Ph.D. President and Chief Executive Officer
pSivida Corp. Names Paul Ashton, Ph.D. President and Chief Executive Officer
HSMN NewsFeed - 26 Nov 2007
Pharmasset Appoints Patrick T. Higgins as Executive Vice President, Marketing & Sales
Pharmasset Appoints Patrick T. Higgins as Executive Vice President, Marketing & Sales
HSMN NewsFeed - 5 Jul 2007
ViroPharma Initiates Phase 3 Study of CAMVIA(TM) (maribavir) in Liver Transplant Patients
ViroPharma Initiates Phase 3 Study of CAMVIA(TM) (maribavir) in Liver Transplant Patients
HSMN NewsFeed - 27 Jun 2007
FDA Grants Fast Track Status for HCV-796 for Treatment of Hepatitis C Virus Infection
FDA Grants Fast Track Status for HCV-796 for Treatment of Hepatitis C Virus Infection
HSMN NewsFeed - 1 May 2007
Robert G. Pietrusko Joins ViroPharma as Vice President of Global Regulatory Affairs and Quality
Robert G. Pietrusko Joins ViroPharma as Vice President of Global Regulatory Affairs and Quality
HSMN NewsFeed - 1 May 2007
ViroPharma Announces Decision To Develop And Commercialize Maribavir In Europe
ViroPharma Announces Decision To Develop And Commercialize Maribavir In Europe
HSMN NewsFeed - 10 Apr 2007
FermaVir Pharmaceuticals, Inc. Signs Definitive Agreement to Be Acquired by Inhibitex, Inc.
FermaVir Pharmaceuticals, Inc. Signs Definitive Agreement to Be Acquired by Inhibitex, Inc.
HSMN NewsFeed - 18 Dec 2006
ZLB Behring Completes Purchase of CytoGam(R) Immunoglobulin Therapy From MedImmune
ZLB Behring Completes Purchase of CytoGam(R) Immunoglobulin Therapy From MedImmune
HSMN NewsFeed - 28 Nov 2006
European Medicines Agency Accepts DOR BioPharma's MAA Filing for orBec(R)
European Medicines Agency Accepts DOR BioPharma's MAA Filing for orBec(R)
HSMN NewsFeed - 9 Nov 2006
Study in Today's New England Journal of Medicine Shows Benefits of Thymoglobulin Use
Study in Today's New England Journal of Medicine Shows Benefits of Thymoglobulin Use
HSMN NewsFeed - 7 Nov 2006
Daniel B. Soland Joins ViroPharma as Vice President and Chief Commercial Officer
Daniel B. Soland Joins ViroPharma as Vice President and Chief Commercial Officer
HSMN NewsFeed - 7 Nov 2006
DOR BioPharma Submits European Marketing Application for orBec(R) to Treat GI Graft-Versus-Host Disease
DOR BioPharma Submits European Marketing Application for orBec(R) to Treat GI Graft-Versus-Host Disease
HSMN NewsFeed - 31 Oct 2006
CytRx's Arimoclomol Granted Orphan Drug Designation in European Union for Treatment of ALS
CytRx's Arimoclomol Granted Orphan Drug Designation in European Union for Treatment of ALS
HSMN NewsFeed - 28 Sep 2006
New Data Reinforce Efficacy of TRIZIVIR(R) Alone in Treatment-Naive HIV Patients with Low Viral Load
New Data Reinforce Efficacy of TRIZIVIR(R) Alone in Treatment-Naive HIV Patients with Low Viral Load
HSMN NewsFeed - 28 Sep 2006
United States Seeing Greater Increases in Clostridium Difficile-Associated Disease Case-Load and Severity
United States Seeing Greater Increases in Clostridium Difficile-Associated Disease Case-Load and Severity
HSMN NewsFeed - 28 Sep 2006
ViroPharma Initiates First of Two Phase 3 Studies of Maribavir in Transplant Patients
ViroPharma Initiates First of Two Phase 3 Studies of Maribavir in Transplant Patients
HSMN NewsFeed - 22 Sep 2006
DOR BioPharma Files New Drug Application with FDA to Market orBec for GI GVHD
DOR BioPharma Files New Drug Application with FDA to Market orBec for GI GVHD
Additional items found! 44

Members Archive contains
44 additional stories matching:
cytomegalovirus
(Password required)
cytomegalovirus
(Password required)